Demystifying the management of hypertriglyceridaemia

@article{Watts2013DemystifyingTM,
  title={Demystifying the management of hypertriglyceridaemia},
  author={Gerald F. M. Watts and Esther M. M. Ooi and Dick C. Chan},
  journal={Nature Reviews Cardiology},
  year={2013},
  volume={10},
  pages={648-661}
}
Hypertriglyceridaemia (typical triglyceride level 1.7–5.0 mmol/l) is caused by interactions between many genetic and nongenetic factors, and is a common risk factor for atherosclerotic cardiovascular disease (CVD). Patients with hypertriglyceridaemia usually present with obesity, insulin resistance, hepatic steatosis, ectopic fat deposition, and diabetes mellitus. Hypertriglyceridaemia reflects the accumulation in plasma of proatherogenic lipoproteins, triglyceride-rich lipoprotein (TRL… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS